Who invested in Syneron Bio?
Syneron Bio's investors include Decheng Capital, CDH VCG, Qiming Venture Partners, 5Y Capital and AstraZeneca, and 6 more on record. Decheng Capital led its latest round.
Who invested in Syneron Bio
One round we have observed, with the 11 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 7 months ago
Follow Syneron Bio and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$150Mraised across 1 round since 2026, from 1 source
- Latest round
- Series B, $150MApr 2026
- Led by
- Decheng Capital and CDH VCG
- Investors
- 11 (2 led)
The rounds
- Apr 2026
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Syneron Bio
How much has Syneron Bio raised?
Syneron Bio has raised $150M across 1 round since 2026.
When did Syneron Bio last raise?
Syneron Bio's most recent round was a Series B of $150M in Apr 2026, led by Decheng Capital.
What was Syneron Bio's biggest round?
Its most recent round, $150M in Apr 2026, is also its largest on record.
Who backed Syneron Bio first?
Syneron Bio's first round on record, in Apr 2026, was backed by Decheng Capital, CDH VCG and Qiming Venture Partners and 8 others.
What stage is Syneron Bio at?
Syneron Bio's latest named round is a Series B, in Apr 2026.
Who led Syneron Bio's rounds?
Decheng Capital led the Series B in 2026.
Companies like Syneron Bio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.